TVWM
TECH icon

Tower View Wealth Management’s Bio-Techne TECH Stock Holding History

Tower View Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-80
Closed -$6K – 212
2020
Q4 		$6K Hold
80
– – ﹤0.01% 152
2020
Q3 		$5K Hold
80
– – ﹤0.01% 137
2020
Q2 		$5K Buy
+80
New +$4.79K ﹤0.01% 130

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Tower View Wealth Management's TECH Position: Q1 2021 in Review

Tower View Wealth Management sold out of Bio-Techne (TECH) in Q1 2021, closing a stake of 80 shares — an estimated $6K sold.

Tower View Wealth Management first reported a position in TECH in Q2 2020 and held it in 3 quarters. The position peaked at $6K in Q4 2020. 470 funds tracked by Wall St. Rank hold TECH as of Q1 2021.

  • Tower View Wealth Management reported no remaining Bio-Techne position as of Q1 2021 after selling out during the quarter.
  • Tower View Wealth Management sold 80 Bio-Techne shares in Q1 2021, an estimated $6K.
  • Tower View Wealth Management first reported a position in Bio-Techne in Q2 2020 and held it in 3 quarters.
  • Tower View Wealth Management's Bio-Techne position peaked at $6K in Q4 2020.
  • 470 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2021.

Based on Tower View Wealth Management's 13F filing for Q1 2021, filed 23 Apr 2021.